|
GB1583602A
(en)
*
|
1977-05-26 |
1981-01-28 |
Sterwin Ag |
N-acetyl-para-aminophenyl-n'-acetyl-amino-thioalkanoic acid ester derivatives
|
|
IT1134458B
(it)
|
1980-11-26 |
1986-08-13 |
Real Sas Di Alberto Reiner |
Derivato della n-acetil-cisteina ad attivita' terapeutica,procedimento per la sua preparazione e relative composizioni farmaceutiche
|
|
IT1194117B
(it)
|
1981-11-20 |
1988-09-14 |
Isnardi Pietro & C Spa |
Derivati salicilici di n-acetilcisteina
|
|
IT1190987B
(it)
*
|
1982-09-07 |
1988-02-24 |
Pharma Edmond Srl |
Tioesteri dell'acido acetilsalicilico,procedimento per la loro preparazione e composizioni farmaceutiche che li conttengono
|
|
IT1206515B
(it)
|
1983-08-09 |
1989-04-27 |
Guidotti & C Spa Labor |
N-acetilcisteina ederivati 2',4's-carbossimetilcisteina ad-difluoro-4-idrossi-(1,1'-bifenil)attivita' antinfiammatoria, 3-carbossilici della mucolitica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
|
|
US5656620A
(en)
*
|
1984-01-28 |
1997-08-12 |
Ismail; Roshdy |
Method for treating pain
|
|
ES8609231A1
(es)
|
1985-12-03 |
1986-09-01 |
Farmhispania |
Procedimiento de obtencion del n-acetil-3(2-(acetiloxi)ben- zoilmercapto)alanina
|
|
ES8800144A1
(es)
|
1986-05-09 |
1987-11-01 |
Lasa Lab |
Procedimiento de obtencion de un tioester de la n-acetilcisteina y de sus sales de interes terapeutico
|
|
EP0254032A3
(en)
*
|
1986-06-20 |
1990-09-05 |
Schering Corporation |
Neutral metalloendopeptidase inhibitors in the treatment of hypertension
|
|
IT1213301B
(it)
|
1986-07-14 |
1989-12-20 |
Zambon Spa |
Composizioni per il trattamento del le sindromi da ischemia e riperfusione
|
|
IT1228537B
(it)
|
1987-07-30 |
1991-06-20 |
Magis Farmaceutici |
Derivati della cisteina ad azione espettorante
|
|
US5610180A
(en)
*
|
1988-01-29 |
1997-03-11 |
Virginia Commonwealth University |
Ionizable congeners of aromatic and aliphatic alcohols as anti-leukemia agents
|
|
US8178516B2
(en)
*
|
1992-06-30 |
2012-05-15 |
Sylvan Labs, LLC |
Compositions and method for treatment of chronic inflammatory diseases
|
|
DE4327462A1
(de)
|
1993-08-16 |
1995-02-23 |
Carl Heinrich Dr Weischer |
Neue N-Acetyl-p-Aminophenol-Derivate zur Bekämpfung von Schmerzzuständen
|
|
RU2054936C1
(ru)
|
1994-04-07 |
1996-02-27 |
Елизарова Евгения Павловна |
Мембраностабилизирующее средство для лечения больных с инсулинзависимым и инсулиннезависимым сахарным диабетом
|
|
DE4444051A1
(de)
*
|
1994-12-10 |
1996-06-13 |
Rhone Poulenc Rorer Gmbh |
Pharmazeutische, oral anwendbare Zubereitung
|
|
US5871769A
(en)
*
|
1996-01-18 |
1999-02-16 |
Fleming & Company, Pharmaceuticals |
Methods and compositions for the prevention and treatment of diabetes mellitus
|
|
CN1230178A
(zh)
*
|
1996-09-10 |
1999-09-29 |
麦地诺克斯公司 |
含聚二硫代氨基甲酸酯的大分子和其用于治疗和诊断应用的用途
|
|
US6896899B2
(en)
*
|
1996-12-31 |
2005-05-24 |
Antioxidant Pharmaceuticals Corp. |
Pharmaceutical preparations of glutathione and methods of administration thereof
|
|
IL123887A0
(en)
*
|
1997-04-02 |
1998-10-30 |
Sankyo Co |
Dithiolan derivatives their use and pharmaceutical compositions containing the same
|
|
AUPO612397A0
(en)
*
|
1997-04-11 |
1997-05-08 |
University Of Queensland, The |
Novel diflunisal esters and related compounds
|
|
EA200800375A1
(ru)
*
|
1997-05-14 |
2008-06-30 |
Атеродженикс, Инк. |
Соединения и способы ингибирования экспрессии vcam-1
|
|
US6852878B2
(en)
*
|
1998-05-14 |
2005-02-08 |
Atherogenics, Inc. |
Thioketals and thioethers for inhibiting the expression of VCAM-1
|
|
US20020004515A1
(en)
*
|
1997-06-18 |
2002-01-10 |
Smith Stephen Alistair |
Treatment of diabetes with thiazolidinedione and metformin
|
|
US5972986A
(en)
*
|
1997-10-14 |
1999-10-26 |
G.D. Searle & Co. |
Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
|
|
US6197340B1
(en)
*
|
1998-05-28 |
2001-03-06 |
Medical Research Institute |
Controlled release lipoic acid
|
|
WO1999063929A2
(en)
*
|
1998-06-08 |
1999-12-16 |
Advanced Medicine, Inc. |
Multibinding inhibitors of microsomal triglyceride transferase protein
|
|
US20020045580A1
(en)
*
|
1999-11-24 |
2002-04-18 |
Sacks Meir S. |
Compositions for raising uric acid levels and methods of using same
|
|
AU5142699A
(en)
*
|
1998-07-31 |
2000-02-28 |
Mount Sinai Hospital Corporation |
Methods and compositions for increasing insulin sensitivity
|
|
IL141967A0
(en)
*
|
1998-09-17 |
2002-03-10 |
Akesis Pharm Inc |
Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
|
|
US6201028B1
(en)
*
|
1998-12-08 |
2001-03-13 |
The Rockefeller University |
Methods and compositions for prevention and treatment of atherosclerosis and hyperlipidemia with non-steroidal anti-inflammatory drugs
|
|
IT1311924B1
(it)
*
|
1999-04-13 |
2002-03-20 |
Nicox Sa |
Composti farmaceutici.
|
|
US20010051184A1
(en)
*
|
1999-05-20 |
2001-12-13 |
Madalene C.Y. Heng |
Method for using soluble curcumin to inhibit phosphorylase kinase in inflammatory diseases
|
|
JP4618845B2
(ja)
|
1999-06-09 |
2011-01-26 |
杏林製薬株式会社 |
ヒトペルオキシゾーム増殖薬活性化受容体（ＰＰＡＲ）αアゴニストとしての置換フェニルプロピオン酸誘導体
|
|
KR20020016833A
(ko)
*
|
1999-06-15 |
2002-03-06 |
뉴트리-로직스, 인크. |
발병 감소에 유용한 영양 제제, 관련 치료 방법 및 성분스크리닝 방법
|
|
US6309663B1
(en)
*
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
|
AU7995300A
(en)
*
|
1999-10-05 |
2001-05-10 |
Bethesda Pharmaceuticals, Inc. |
Dithiolane derivatives
|
|
US7323496B2
(en)
*
|
1999-11-08 |
2008-01-29 |
Theracos, Inc. |
Compounds for treatment of inflammation, diabetes and related disorders
|
|
US20020155163A1
(en)
*
|
1999-12-27 |
2002-10-24 |
Samuel D. Benjamin |
Integrated multi-vitamin and mineral combination
|
|
US20080213785A1
(en)
*
|
2000-04-20 |
2008-09-04 |
Andrew Levy |
Method of predicting a benefit of antioxidant therapy for prevention or treatment of vasclar disease in hyperglycemic individuals
|
|
US20080044399A1
(en)
*
|
2000-04-20 |
2008-02-21 |
Andrew Levy |
Vitamin E supplementation for reducing cardiovascular events in individuals with DM and the Hp 2-2 genotype
|
|
US20020037855A1
(en)
*
|
2000-05-05 |
2002-03-28 |
Fritz Stanislaus |
Stabilized medicament containing cysteinyl derivatives
|
|
US6355666B1
(en)
*
|
2000-06-23 |
2002-03-12 |
Medinox, Inc. |
Protected forms of pharmacologically active agents and uses therefor
|
|
US6429223B1
(en)
*
|
2000-06-23 |
2002-08-06 |
Medinox, Inc. |
Modified forms of pharmacologically active agents and uses therefor
|
|
US6365176B1
(en)
*
|
2000-08-08 |
2002-04-02 |
Functional Foods, Inc. |
Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy
|
|
IT1319201B1
(it)
*
|
2000-10-12 |
2003-09-26 |
Nicox Sa |
Farmaci per il diabete.
|
|
US20020098247A1
(en)
*
|
2000-11-02 |
2002-07-25 |
Komorowski James R. |
Methods and compositions for the improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes and alpha lipoic acid
|
|
US6589948B1
(en)
*
|
2000-11-28 |
2003-07-08 |
Eukarion, Inc. |
Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases
|
|
ES2375268T3
(es)
*
|
2000-12-14 |
2012-02-28 |
The Brigham And Women's Hospital, Inc. |
Marcadores inflamatorios para la detección y prevención de diabetes mellitus.
|
|
EP1219304B1
(de)
|
2000-12-28 |
2004-10-20 |
Fresenius Kabi Austria GmbH |
Stabile Infusionslösung von Diclofenac-Salzen, deren Herstellung und Verwendung
|
|
WO2004096256A1
(en)
*
|
2001-01-23 |
2004-11-11 |
The United States Of America, As Represented By The Secretary Of The Navy |
Methods for preventing and treating loss of balance function due to oxidative stress
|
|
JP2002226457A
(ja)
*
|
2001-02-02 |
2002-08-14 |
Ajinomoto Co Inc |
新規シスチン誘導体及び炎症因子活性化抑制剤
|
|
US6566401B2
(en)
*
|
2001-03-30 |
2003-05-20 |
The Board Of Trustees Of The Leland Stanford Junior University |
N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
|
|
RS20100077A
(sr)
*
|
2001-04-30 |
2010-10-31 |
Trommsdorff Gmbh. & Co. Kg. Arzneimittel |
Farmaceutski aktivni estri uridina
|
|
US6669955B2
(en)
*
|
2001-08-28 |
2003-12-30 |
Longwood Pharmaceutical Research, Inc. |
Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
|
|
US20050019399A1
(en)
*
|
2001-09-21 |
2005-01-27 |
Gina Fischer |
Controlled release solid dispersions
|
|
FR2835433B1
(fr)
|
2002-02-01 |
2006-02-17 |
Richard Lab M |
Utilisation de la 1-(-4-chlorobenzoyl)-5methoxy-2-methyl-1h- indole-3acetic 4-(acetylamino)phenylester pour la fabrication d'un medicament destine a inhiber exclusivement la cox2
|
|
AU2003220342B2
(en)
*
|
2002-03-14 |
2007-06-07 |
Bayer Pharmaceuticals Corporation |
Methods of treating diabetes using PDE 11A inhibitors
|
|
US7670612B2
(en)
*
|
2002-04-10 |
2010-03-02 |
Innercap Technologies, Inc. |
Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
|
|
AU2003253887A1
(en)
*
|
2002-07-12 |
2004-02-02 |
Atherogenics, Inc. |
Novel salt forms of poorly soluble probucol esters and ethers
|
|
US7148211B2
(en)
*
|
2002-09-18 |
2006-12-12 |
Genzyme Corporation |
Formulation for lipophilic agents
|
|
CA2504329C
(en)
*
|
2002-11-01 |
2013-08-20 |
Biodelivery Sciences International, Inc. |
Geodate delivery vehicles
|
|
CN1233629C
(zh)
|
2002-11-22 |
2005-12-28 |
贵州省中国科学院天然产物化学重点实验室 |
具有神经营养作用的硫酯类化合物及其它的合成方法和应用
|
|
US8017651B2
(en)
*
|
2002-11-22 |
2011-09-13 |
Bionexus, Ltd. |
Compositions and methods for the treatment of HIV-associated fat maldistribution and hyperlipidemia
|
|
US8093292B2
(en)
*
|
2002-11-22 |
2012-01-10 |
Bionexus, Ltd. |
Methods for the treatment of HIV-1 related fat maldistribution, fasting hyperlipidemia and modification of adipocyte physiology
|
|
MXPA02012315A
(es)
*
|
2002-12-13 |
2004-06-24 |
Univ Autonoma Metropolitana |
Compuesto farmaceutico que contiene silimarina y carbopol, su proceso de fabricacion y su uso como regenerador del tejido y celulas pancreaticas de secrecion endogena danados por diabetes mellitus.
|
|
WO2006066894A1
(en)
*
|
2004-12-24 |
2006-06-29 |
Ctg Pharma S.R.L. |
Compounds for treating metabolic syndrome
|
|
US20090036516A1
(en)
*
|
2003-01-13 |
2009-02-05 |
Ctg Pharma S.R.L. |
Compounds for treating metabolic syndrome
|
|
US20050020654A1
(en)
*
|
2003-03-15 |
2005-01-27 |
Pershadsingh Harrihar A. |
Novel PPAR agonists, pharmaceutical compositions and uses thereof
|
|
US7981915B2
(en)
*
|
2003-04-30 |
2011-07-19 |
Beth Israel Deaconess Medical Center |
Methods for modulating PPAR biological activity for the treatment of diseases caused by mutations in the CFTR gene
|
|
AT500404A1
(de)
*
|
2003-07-17 |
2005-12-15 |
Jsw Res Forschungslabor Gmbh |
Chemische verbindungen enthaltend tocopherol sowie zumindest einen weiteren pharmazeutischen wirkstoff
|
|
US8173840B2
(en)
*
|
2003-07-29 |
2012-05-08 |
Signature R&D Holdings, Llc |
Compounds with high therapeutic index
|
|
EP1667640B1
(de)
|
2003-09-22 |
2009-08-05 |
JUVENA (International) AG |
Haut- und haarpflegezubereitung enthaltend proteinhydrolysate
|
|
US20070254055A1
(en)
*
|
2003-11-21 |
2007-11-01 |
Trustees Of Tufts College |
Therapeutic Avenanthramide Compounds
|
|
US7078064B2
(en)
*
|
2003-12-03 |
2006-07-18 |
George Zabrecky |
Compositions and methods useful for treating and preventing chronic liver disease, chronic HCV infection and non-alcoholic steatohepatitis
|
|
US20050143356A1
(en)
*
|
2003-12-08 |
2005-06-30 |
Vanderbilt University |
Selective inhibition of cyclooxygenase 1 in the treatment of diabetic nephropathy
|
|
EP1708689A2
(en)
|
2003-12-29 |
2006-10-11 |
The President and Fellows of Harvard College |
Compositions for treating or preventing obesity and insulin resistance disorders
|
|
DE602004025151D1
(de)
|
2004-03-10 |
2010-03-04 |
Shimoda Biotech Pty Ltd |
Stabile injizierbare Diclofenac- Zubereitungen
|
|
CN1956726B
(zh)
*
|
2004-03-23 |
2011-04-13 |
生命线营养健康公司 |
用于缓解哺乳动物炎症及氧化应激的组合物和方法
|
|
WO2005112914A2
(en)
*
|
2004-04-20 |
2005-12-01 |
Atherogenics, Inc. |
Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease
|
|
MXPA06013463A
(es)
*
|
2004-05-17 |
2007-03-01 |
Combinatorx Inc |
Metodos y reactivos para el tratamiento de desordenes inmuno-inflamatorios.
|
|
JP4218601B2
(ja)
|
2004-06-29 |
2009-02-04 |
トヨタ自動車株式会社 |
圧縮着火内燃機関の空燃比センサ劣化判定システム
|
|
WO2006004803A1
(en)
*
|
2004-06-30 |
2006-01-12 |
Combinatorx, Incorporated |
Methods and reagents for the treatment of metabolic disorders
|
|
US8252321B2
(en)
*
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
|
US20080038316A1
(en)
*
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
|
AU2005296565A1
(en)
*
|
2004-10-22 |
2006-04-27 |
Kirin Beer Kabushiki Kaisha |
Transcriptional factor Nrf2 activator and food having the function of the same imparted thereto
|
|
US20060099279A1
(en)
*
|
2004-11-09 |
2006-05-11 |
Council Of Scientific & Industrial Research |
Novel anti-diabetic herbal formulation
|
|
EP1930046A1
(en)
*
|
2004-12-08 |
2008-06-11 |
Sirion Therapeutics, Inc. |
Retinol binding protein and transthyretin modulators for treating diabetes
|
|
US20060166901A1
(en)
*
|
2005-01-03 |
2006-07-27 |
Yu Ruey J |
Compositions comprising O-acetylsalicyl derivatives of aminocarbohydrates and amino acids
|
|
AU2006206274A1
(en)
*
|
2005-01-20 |
2006-07-27 |
Sirtris Pharmaceuticals, Inc. |
Use of sirtuin-activating compounds for treating flushing and drug induced weight gain
|
|
US20080279897A1
(en)
*
|
2005-01-21 |
2008-11-13 |
Medvet Science Pty. Ltd. |
Method of Treating Cellular Damage
|
|
US20060172012A1
(en)
*
|
2005-01-28 |
2006-08-03 |
Finley John W |
Anti-inflammatory supplement compositions and regimens to reduce cardiovascular disease risks
|
|
US20080033027A1
(en)
*
|
2005-03-21 |
2008-02-07 |
Vicus Therapeutics Spe 1, Llc |
Drug combination pharmaceutical compositions and methods for using them
|
|
CA2646131C
(en)
*
|
2005-03-21 |
2018-09-04 |
Vicus Therapeutics Spe 1, Llc |
Compositions and methods for ameliorating cachexia
|
|
CA2606053A1
(en)
*
|
2005-04-21 |
2006-11-02 |
Glenn Goldstein |
N-acetylcysteine amide (nac amide) for the treatment of diseases and conditions associated with oxidative stress
|
|
US20060270635A1
(en)
*
|
2005-05-27 |
2006-11-30 |
Wallace John L |
Derivatives of 4- or 5-aminosalicylic acid
|
|
US20070149466A1
(en)
*
|
2005-07-07 |
2007-06-28 |
Michael Milburn |
Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
|
|
US20090325975A1
(en)
*
|
2005-07-15 |
2009-12-31 |
Helmut H Buschmann |
Use of compounds binding to the sigma receptor for the treatment of diabetes-associated pain
|
|
US7345178B2
(en)
*
|
2005-08-04 |
2008-03-18 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
|
EP1960356A2
(en)
*
|
2005-11-03 |
2008-08-27 |
Ilypsa, Inc. |
Multivalent indole compounds and use thereof as phospholipase-a2 inhibitors
|
|
DE102005057178A1
(de)
|
2005-11-30 |
2007-07-19 |
Basf Ag |
Verwendung von Zinksalzen der Liponsäure zur Behandlung von Fettstoffwechselstörungen
|
|
US20070248590A1
(en)
*
|
2005-12-02 |
2007-10-25 |
Sirtris Pharmaceuticals, Inc. |
Modulators of CDC2-like kinases (CLKS) and methods of use thereof
|
|
WO2007067570A1
(en)
*
|
2005-12-05 |
2007-06-14 |
Biomarin Pharmaceutical Inc. |
Methods and compositions for the treatment of disease
|
|
US20070231273A1
(en)
*
|
2006-03-31 |
2007-10-04 |
Jie Wu |
Method for Decreasing Blood Glucose Levels
|
|
WO2007117048A1
(en)
|
2006-04-10 |
2007-10-18 |
Seoul National University Industry Foundation |
Inhibitors against g6pd enzyme for treating and preventing oxidative stress and/or inflammatory related diseases and method for screening the same
|
|
US20080015251A1
(en)
*
|
2006-04-10 |
2008-01-17 |
Yissum Research Development Co., Of The Hebrew University Of Jerusalem |
Means and method for treating lipotoxicity and other metabolically related phenomena
|
|
WO2007127913A2
(en)
|
2006-04-28 |
2007-11-08 |
Joslin Diabetes Center, Inc. |
Reducing risk of type 2 diabetes (t2d)
|
|
AU2006346195B2
(en)
*
|
2006-07-09 |
2013-03-07 |
Techfields Biochem Co. Ltd |
Positively charged water-soluble prodrugs of aspirin
|
|
HUE033687T2
(en)
*
|
2006-07-18 |
2017-12-28 |
Techfields Biochem Co Ltd |
Ibuprofen positively charged water soluble prodrugs with very fast skin penetration rates
|
|
PL2046727T3
(pl)
*
|
2006-07-25 |
2014-08-29 |
Techfields Biochem Co Ltd |
Dodatnio naładowane rozpuszczalne w wodzie proleki diklofenaku o bardzo szybkim stopniu przenikania przez skórę
|
|
CN101500983B
(zh)
*
|
2006-07-26 |
2015-09-16 |
于崇曦 |
具有快速皮肤穿透速度的带正电荷的水溶性二氟尼柳及相关化合物的前药
|
|
US20080139525A1
(en)
*
|
2006-08-31 |
2008-06-12 |
The Brigham And Women's Hospital, Inc. |
Antioxidant therapies
|
|
EP3388417A1
(en)
*
|
2006-09-03 |
2018-10-17 |
Techfields Biochem Co. Ltd |
Positively charged water-soluble prodrugs of acetaminophen and related compounds with very fast skin penetration rate
|
|
EP2069477A4
(en)
*
|
2006-10-06 |
2010-12-08 |
Celtaxsys Inc |
Chemorepulsion of cells
|
|
US7498048B2
(en)
*
|
2006-11-16 |
2009-03-03 |
Jose Angel Olalde Rangel |
Renal phyto-nutraceutical composition
|
|
SG178716A1
(en)
*
|
2007-01-16 |
2012-03-29 |
Ipintl Llc |
Novel composition for treating metabolic syndrome
|
|
DE602008002733D1
(de)
*
|
2007-03-08 |
2010-11-04 |
Irm Llc |
Verbindungen und zusammensetzungen als modulatoren der gpr119-aktivität
|
|
US20090169497A1
(en)
*
|
2007-12-31 |
2009-07-02 |
Horwitz Lawrence D |
Treatment and Prevention of Skin Injury Due to Exposure to Ultraviolet Light
|
|
WO2009089011A2
(en)
|
2008-01-08 |
2009-07-16 |
Sirtris Pharmaceuticals, Inc. |
Resveratrol formulations
|
|
CN102316730A
(zh)
*
|
2008-05-09 |
2012-01-11 |
天雅瑞药业有限公司 |
用于减轻全身性炎症和/或血管炎症的n-乙酰半胱氨酸(nac)的控释
|
|
CN102088965B
(zh)
*
|
2008-05-13 |
2013-05-08 |
根梅迪卡治疗公司 |
水杨酸盐(酯)缀合物在制备用于治疗代谢性病症的药物中的应用
|
|
CN102421424A
(zh)
*
|
2009-03-16 |
2012-04-18 |
根梅迪卡治疗公司 |
用于治疗代谢性疾病的组合疗法
|